A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Dose Study To Investigate The Effects Of 8 Mg Fesoterodine SR Tablets And 10 Mg Solifenacin Tablet On Gastrointestinal Transit In Healthy Female Subjects.

Trial Profile

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Dose Study To Investigate The Effects Of 8 Mg Fesoterodine SR Tablets And 10 Mg Solifenacin Tablet On Gastrointestinal Transit In Healthy Female Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 Apr 2013

At a glance

  • Drugs Fesoterodine (Primary) ; Solifenacin
  • Indications Overactive bladder
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Feb 2013 New source identified and integrated (Mayo Clinic; 09-000944).
    • 23 Dec 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov (NCT00832650).
    • 23 Dec 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov (NCT00832650).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top